Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
dyne therapeutics
3
×
life sciences
national blog main
san diego blog main
boston
clinical trials
metacrine
myotonic dystrophy type 1
national top stories
new york blog main
rare disease drugs
san diego top stories
san francisco blog main
vertex pharmaceuticals
abbvie
allergan aesthetics
alzheimer's disease
amgen
astellas pharma
astrazeneca
athira pharma
atlas venture
attralus
audentes therapeutics
avidity biosciences
biontech
biotech ipos
bluebird bio
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
covid-19
What
drug
dyne
dyne’s
genetic
ipo
medicines
muscle
rare
therapeutics
acquisitions
ago
biggest
bio
biotechs
brings
build
buy
ceo
company
company’s
considering
daniel
data
debut
developing
diseases
disorders
early
expected
experimental
eyes
gilead
having
humans
ipos
long
microbiome
million
moves
muscular
Language
unset
Current search:
" dyne therapeutics "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
